Pro-Cure Therapeutics

France
Anneyron, Rhône-Alpes, France, YO10 5NY

Company profile

Pro-Cure Therapeutics company profile

Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.

Business identity

Contact email
[email protected]
Phone number
44 1904 435 125
Operating status
Active
Company type
For Profit
Founded
2001-01-01, Year

Headquarters

Postal code
YO10 5NY
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$2.2M
Last funding
Series Unknown / $1.1M / 2010-04-13
Last equity funding
Series Unknown / $1.1M
Investors
4
Lead investors
2
Articles
1

Founders and investors

Lead investors

White Rose Technology Seedcorn FundYorkshire Cancer Research

Investors

Maven Capital PartnersSMH Venture Finance LimitedWhite Rose Technology Seedcorn FundYorkshire Cancer Research